226 related articles for article (PubMed ID: 3862124)
1. A possible mechanism of psoralen phototoxicity not involving direct interaction with DNA.
Laskin JD; Lee E; Yurkow EJ; Laskin DL; Gallo MA
Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6158-62. PubMed ID: 3862124
[TBL] [Abstract][Full Text] [Related]
2. Psoralenamines. 3. Synthesis, pharmacological behavior, and DNA binding of 5-(aminomethyl)-8-methoxy-, 5-[[(3-aminopropyl)oxy]methyl]-, and 8-[(3-aminopropyl)oxy]psoralen derivatives.
Hansen JB; Bjerring P; Buchardt O; Ebbesen P; Kanstrup A; Karup G; Knudsen PH; Nielsen PE; Nordén B; Ygge B
J Med Chem; 1985 Aug; 28(8):1001-10. PubMed ID: 4020822
[TBL] [Abstract][Full Text] [Related]
3. Psoralens potentiate ultraviolet light-induced inhibition of epidermal growth factor binding.
Laskin JD; Lee E; Laskin DL; Gallo MA
Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8211-5. PubMed ID: 3490664
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a photoalkylated psoralen receptor in HeLa cells.
Yurkow EJ; Laskin JD
J Biol Chem; 1987 Jun; 262(18):8439-42. PubMed ID: 3036814
[TBL] [Abstract][Full Text] [Related]
5. Psoralen binding and inhibition of epidermal growth factor binding by psoralen/ultraviolet light (PUVA) in human epithelial cells.
Laskin JD; Lee E
Biochem Pharmacol; 1991 Jan; 41(1):125-32. PubMed ID: 1846071
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of psoralens: isobologram analysis reveals that ultraviolet light potentiation of psoralen action is not additive but synergistic.
Yurkow EJ; Laskin JD
Cancer Chemother Pharmacol; 1991; 27(4):315-9. PubMed ID: 1998988
[TBL] [Abstract][Full Text] [Related]
7. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD.
Pathak MA; Fitzpatrick TB
J Photochem Photobiol B; 1992 Jun; 14(1-2):3-22. PubMed ID: 1432383
[TBL] [Abstract][Full Text] [Related]
8. Production of active oxygen species (1O2 and O2-.) by psoralens and ultraviolet radiation (320-400 nm).
Pathak MA; Joshi PC
Biochim Biophys Acta; 1984 Mar; 798(1):115-26. PubMed ID: 6322854
[TBL] [Abstract][Full Text] [Related]
9. Tracing the Photoaddition of Pharmaceutical Psoralens to DNA.
Diekmann J; Theves I; Thom KA; Gilch P
Molecules; 2020 Nov; 25(22):. PubMed ID: 33182821
[TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular mechanisms in photochemical sensitization: studies on the mechanism of action of psoralens.
Laskin JD
Food Chem Toxicol; 1994 Feb; 32(2):119-27. PubMed ID: 8132171
[TBL] [Abstract][Full Text] [Related]
11. Psoralen-protein photochemistry--a forgotten field.
Schmitt IM; Chimenti S; Gasparro FP
J Photochem Photobiol B; 1995 Feb; 27(2):101-7. PubMed ID: 7714670
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of new psoralen derivatives with superior photoreactivity with DNA and RNA.
Isaacs ST; Shen CK; Hearst JE; Rapoport H
Biochemistry; 1977 Mar; 16(6):1058-64. PubMed ID: 849407
[TBL] [Abstract][Full Text] [Related]
13. The nature and molecular basis of cutaneous photosensitivity reactions to psoralens and coal tar.
Pathak MA; Joshi PC
J Invest Dermatol; 1983 Jun; 80 Suppl():66s-74s. PubMed ID: 6854058
[TBL] [Abstract][Full Text] [Related]
14. Cell-impermeant pyridinium derivatives of psoralens as inhibitors of keratinocyte growth.
Mariano TM; Vetrano AM; Gentile SL; Heck DE; Whittemore MS; Guillon CD; Jabin I; Rapp RD; Heindel ND; Laskin JD
Biochem Pharmacol; 2002 Jan; 63(1):31-9. PubMed ID: 11754871
[TBL] [Abstract][Full Text] [Related]
15. Mutagenesis by 8-methoxypsoralen and 5-methylangelicin photoadducts in mouse fibroblasts: mutations at cross-linkable sites induced by offoadducts as well as cross-links.
Gunther EJ; Yeasky TM; Gasparro FP; Glazer PM
Cancer Res; 1995 Mar; 55(6):1283-8. PubMed ID: 7882323
[TBL] [Abstract][Full Text] [Related]
16. Green tea protects against psoralen plus ultraviolet A-induced photochemical damage to skin.
Zhao JF; Zhang YJ; Jin XH; Athar M; Santella RM; Bickers DR; Wang ZY
J Invest Dermatol; 1999 Dec; 113(6):1070-5. PubMed ID: 10594754
[TBL] [Abstract][Full Text] [Related]
17. Effect of psoralen plus ultraviolet A radiation on in vivo growth of melanoma cells.
Aubin F; Donawho CK; Kripke ML
Cancer Res; 1991 Nov; 51(21):5893-7. PubMed ID: 1933857
[TBL] [Abstract][Full Text] [Related]
18. Sequence specificity of psoralen photobinding to DNA: a quantitative approach.
Gia O; Magno SM; Garbesi A; Colonna FP; Palumbo M
Biochemistry; 1992 Dec; 31(47):11818-22. PubMed ID: 1445915
[TBL] [Abstract][Full Text] [Related]
19. PUVA (psoralen + UVA) photochemotherapy: processes triggered in the cells.
Zarebska Z; Waszkowska E; Caffieri S; Dall'Acqua F
Farmaco; 2000 Aug; 55(8):515-20. PubMed ID: 11132728
[TBL] [Abstract][Full Text] [Related]
20. Defective DNA endonuclease activities in Fanconi's anemia cells, complementation groups A and B.
Lambert MW; Tsongalis GJ; Lambert WC; Hang B; Parrish DD
Mutat Res; 1992 Jan; 273(1):57-71. PubMed ID: 1376436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
